warm antibody autoimmune hemolytic anemia
Showing 1 - 5 of 5
Warm Antibody Autoimmune Hemolytic Anemia Trial (HMPL-523(300mg PO QD), Placebo)
Not yet recruiting
- Warm Antibody Autoimmune Hemolytic Anemia
- HMPL-523(300mg PO QD)
- Placebo
- (no location specified)
Sep 7, 2022
Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in
Recruiting
- Autoimmune Hemolytic Anemia
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 9, 2022
Warm Antibody Autoimmune Hemolytic Anemia Trial in Worldwide (Fostamatinib disodium)
Enrolling by invitation
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib disodium
-
Los Angeles, California
- +36 more
Mar 2, 2022
Warm Antibody Autoimmune Hemolytic Anemia Trial in Worldwide (Fostamatinib disodium, Placebo)
Active, not recruiting
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib disodium
- Placebo
-
Gilbert, Arizona
- +101 more
Nov 24, 2021
Warm Antibody Autoimmune Hemolytic Anemia Trial in Canada, United States (Fostamatinib 150 mg bid)
Completed
- Warm Antibody Autoimmune Hemolytic Anemia
- Fostamatinib 150 mg bid
-
Gilbert, Arizona
- +35 more
Jul 19, 2021